110 related articles for article (PubMed ID: 11012219)
1. A new transgenic mouse model for the study of cell cycle control in megakaryocytes.
Thompson A; Zhao Z; Ladd D; Zimmet J; Ravid K
Stem Cells; 1996; 14 Suppl 1():181-7. PubMed ID: 11012219
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D3 and megakaryocyte development: exploration of a transgenic phenotype.
Zimmet JM; Toselli P; Ravid K
Stem Cells; 1998; 16 Suppl 2():97-106. PubMed ID: 11012182
[TBL] [Abstract][Full Text] [Related]
3. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness.
Mintern J; Williams N; Jackson H
Exp Hematol; 1997 Nov; 25(12):1233-9. PubMed ID: 9357966
[TBL] [Abstract][Full Text] [Related]
4. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
Dolnikov A; Millington M; Sun LQ; Symonds G
Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cyclin D1 moderately increases ploidy in megakaryocytes.
Sun S; Zimmet JM; Toselli P; Thompson A; Jackson CW; Ravid K
Haematologica; 2001 Jan; 86(1):17-23. PubMed ID: 11146565
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic differentiation of embryonic stem cells: an in vitro model to study gene regulation during megakaryocytopoiesis.
Uzan G; Prandini MH; Rosa JP; Berthier R
Stem Cells; 1996; 14 Suppl 1():194-9. PubMed ID: 11012221
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells.
Ausserlechner MJ; Obexer P; Böck G; Geley S; Kofler R
Cell Death Differ; 2004 Feb; 11(2):165-74. PubMed ID: 14576768
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
Factor VM; Jensen MR; Thorgeirsson SS
Hepatology; 1997 Dec; 26(6):1434-43. PubMed ID: 9397983
[TBL] [Abstract][Full Text] [Related]
9. Hemopoietic neoplasms in lethally irradiated mice repopulated with bone marrow cells carrying the human c-myc oncogene: a repopulation assay.
Hirabayashi Y; Inoue T; Suda Y; Aizawa S; Ikawa Y; Kanisawa M
Exp Hematol; 1992 Feb; 20(2):167-72. PubMed ID: 1544384
[TBL] [Abstract][Full Text] [Related]
10. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
[TBL] [Abstract][Full Text] [Related]
11. The role of interleukin 6 and interleukin 1 in megakaryocyte development.
Warren MK; Conroy LB; Rose JS
Exp Hematol; 1989 Dec; 17(11):1095-9. PubMed ID: 2583253
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes.
Chanprasert S; Geddis AE; Barroga C; Fox NE; Kaushansky K
Cell Signal; 2006 Aug; 18(8):1212-8. PubMed ID: 16380230
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cells from fancc(-/-) mice have lower growth and differentiation potential in response to growth factors.
Aubé M; Lafrance M; Charbonneau C; Goulet I; Carreau M
Stem Cells; 2002; 20(5):438-47. PubMed ID: 12351814
[TBL] [Abstract][Full Text] [Related]
14. Increased progenitor proliferation and apoptotic cell death in the sensory lineage of mice overexpressing N-myc.
Kobayashi M; Hjerling-Leffler J; Ernfors P
Cell Tissue Res; 2006 Jan; 323(1):81-90. PubMed ID: 16133151
[TBL] [Abstract][Full Text] [Related]
15. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
Smith DP; Bath ML; Harris AW; Cory S
Oncogene; 2005 May; 24(22):3544-53. PubMed ID: 15688022
[TBL] [Abstract][Full Text] [Related]
16. Myc lacks E2F1's ability to suppress skin carcinogenesis.
Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
[TBL] [Abstract][Full Text] [Related]
17. Accelerated growth of hepatocytes in association with Up-regulation of cyclin E in transgenic mice expressing the dominant negative form of retinoic acid receptor.
Tsutusmi A; Shiota G; Yamazaki H; Kunisada T; Terada T; Kawasaki H
Biochem Biophys Res Commun; 2000 Nov; 278(1):229-35. PubMed ID: 11071877
[TBL] [Abstract][Full Text] [Related]
18. Disparate effects of interleukin 11 and thrombopoietin on megakaryocytopoiesis in vitro.
Taguchi K; Saitoh M; Arai Y; Momose K; Ogawa Y; Yasuda S; Miyata K
Cytokine; 2001 Sep; 15(5):241-9. PubMed ID: 11594788
[TBL] [Abstract][Full Text] [Related]
19. Developmental stage determines the effects of MYC in the mammary epithelium.
Blakely CM; Sintasath L; D'Cruz CM; Hahn KT; Dugan KD; Belka GK; Chodosh LA
Development; 2005 Mar; 132(5):1147-60. PubMed ID: 15689376
[TBL] [Abstract][Full Text] [Related]
20. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
